Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Yep, zero debt, strong cashflow, yoy growth, love this one.
Starting to catch up... looking good.
It was a press release of the article that has been doing the rounds of late:
https://www.ophthalmologytimes.com/view/n4-pharma-moving-novel-delivery-systems-towards-commercialization
“Non-viral, non-lipid delivery systems are in high demand in the exciting gene therapy and oncology spaces and we now have two such delivery systems,” Nigel Theobald, CEO of N4 Pharma, said in the company’s news release. “Nuvec continues to show its versatility as a novel delivery system and with LipTide we are developing our first commercial product which we are aiming to take into phase 1 clinical trials.”
'The company will now engage in discussions with the FDA and MHRA to approve a GLP toxicity study and first in human clinical trials.'
Yep, don't think many problems, here. If price goes lower and funds available, just buy more IMO.
Phil did mention in the presentation that he thought it would be difficult for a takeover offer to get voted through due to the large shareholdings of Bosch and Weichai. If either Bosch / Weichai however wanted to make a bid, then who knows...